Cooley LLP represented Structure Therapeutics, while Latham & Watkins LLP represented the underwriters in the offering. Structure Therapeutics, a clinical-stage global biopharmaceutical company, announced its $185.3 million...
Structure Therapeutics’ $185.3 Million IPO
Carlyle and Abingworth’s $170 Million Non-dilutive Financing of Opthea
Goodwin Procter and Debevoise & Plimpton advised Carlyle on the deal, while Cooley and Gilbert+Tobin advised Opthea. Global investment firm Carlyle and its life sciences franchise...
Allbirds’ $302,8 Million Initial Public Offering
Latham & Watkins represented the underwriters in the offering while Cooley advised Allbirds. Allbirds, Inc., a global lifestyle brand that innovates with naturally derived materials to...
Samsung Display’s US$1.5 Billion Sale of Shares in Corning
O’Melveny & Myers LLP advised Samsung Display Co., while Wachtell, Lipton, Rosen & Katz advised Corning on the deal. Samsung Display Co., Ltd. announced the US$5 billion...